These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28556232)

  • 1. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
    Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
    Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
    Maloney JA; Bainbridge T; Gustafson A; Zhang S; Kyauk R; Steiner P; van der Brug M; Liu Y; Ernst JA; Watts RJ; Atwal JK
    J Biol Chem; 2014 Nov; 289(45):30990-1000. PubMed ID: 25253696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
    Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
    Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    Guyon A; Rousseau J; Lamothe G; Tremblay JP
    PLoS One; 2020; 15(12):e0237122. PubMed ID: 33370284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the function of ABCA7 in Alzheimer's disease.
    Li H; Karl T; Garner B
    Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
    Wang LS; Naj AC; Graham RR; Crane PK; Kunkle BW; Cruchaga C; Murcia JD; Cannon-Albright L; Baldwin CT; Zetterberg H; Blennow K; Kukull WA; Faber KM; Schupf N; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Rogaeva E; ; Lin CF; Dombroski BA; Cantwell LB; Partch A; Valladares O; Hakonarson H; St George-Hyslop P; Green RC; Goate AM; Foroud TM; Carney RM; Larson EB; Behrens TW; Kauwe JS; Haines JL; Farrer LA; Pericak-Vance MA; Mayeux R; Schellenberg GD; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barmada M; Barnes LL; Beach TG; Becker JT; Beecham GW; Beekly D; Bennett DA; Bigio EH; Bird TD; Blacker D; Boeve BF; Bowen JD; Boxer A; Burke JR; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carroll SL; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Demirci FY; Dick M; Dickson DW; Duara R; Ertekin-Taner N; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Graff-Radford NR; Growdon JH; Hamilton RL; Hamilton-Nelson KL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jarvik GP; Jicha GA; Jin LW; Jun G; Jun G; Kamboh MI; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lopez OL; Lunetta KL; Lyketsos CG; Mack WJ; Marson DC; Martin ER; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam WM; Miller BL; Miller CA; Miller JW; Montine TJ; Morris JC; Murrell JR; Olichney JM; Parisi JE; Perry W; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reiman EM; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Tsuang DW; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
    JAMA Neurol; 2015 Feb; 72(2):209-16. PubMed ID: 25531812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
    Nilsberth C; Westlind-Danielsson A; Eckman CB; Condron MM; Axelman K; Forsell C; Stenh C; Luthman J; Teplow DB; Younkin SG; Näslund J; Lannfelt L
    Nat Neurosci; 2001 Sep; 4(9):887-93. PubMed ID: 11528419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
    Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
    Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
    Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
    Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating APP, NCAM and Aβ serve as biomarkers for Alzheimer's disease.
    Chen K; Gao T; Bai Z; Yuan Z
    Brain Res; 2018 Nov; 1699():117-120. PubMed ID: 30118716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
    Bamne MN; Demirci FY; Berman S; Snitz BE; Rosenthal SL; Wang X; Lopez OL; Kamboh MI
    Neurobiol Aging; 2014 Jul; 35(7):1779.e15-6. PubMed ID: 24529499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.
    Kero M; Paetau A; Polvikoski T; Tanskanen M; Sulkava R; Jansson L; Myllykangas L; Tienari PJ
    Neurobiol Aging; 2013 May; 34(5):1518.e1-3. PubMed ID: 23102935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
    Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
    Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases.
    Ting SK; Chong MS; Kandiah N; Hameed S; Tan L; Au WL; Prakash KM; Pavanni R; Lee TS; Foo JN; Bei JX; Yu XQ; Liu JJ; Zhao Y; Lee WL; Tan EK
    Neurobiol Aging; 2013 Oct; 34(10):2441.e7-8. PubMed ID: 23652020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
    Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
    J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.